Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing KEB Biotechnology is a specialized medical diagnostics company headquartered in Beijing, China, focusing on the development and manufacture of in vitro diagnostic (IVD) solutions. The company primarily utilizes colloidal gold and ELISA (Enzyme-Linked Immunosorbent Assay) platforms to produce rapid test kits for a variety of clinical applications. Its extensive product portfolio includes diagnostics for infectious diseases such as HIV, Hepatitis, Malaria, and Dengue, as well as tests for drugs of abuse, cardiac markers, and fertility. KEB Biotechnology operates a large-scale manufacturing facility that adheres to international quality standards, including ISO 13485, and serves a global market spanning hospitals, clinical laboratories, and point-of-care settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KEB Biotechnology.